Salary
💰 $205,000 - $270,000 per year
About the role
- Cogent Biosciences is a publicly traded biotechnology company focused on developing precision therapies for genetically defined diseases.
- The most advanced clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17.
- KIT D816V is responsible for driving systemic mastocytosis (SM), a serious disease caused by unchecked proliferation of mast cells.
- Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
- Top-line results from registration-directed trials in NonAdvanced SM, Advanced SM and GIST are expected in 2025.
- The company also has an ongoing Phase 1 study of its novel internally discovered FGFR2 inhibitor.
- In addition, the Cogent Research Team is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases targeting mutations in ErbB2, PI3Kα and KRAS.
- Our Team: https://cogent.culturehq.com
Requirements
- In collaboration with the Executive Medical Director in Clinical Development and key Cogent R&D stakeholders, contribute to the clinical development and regulatory submissions for bezuclastinib.
- Oversee all aspects of clinical science activities for bezuclastinib to ensure the successful execution and reporting of ongoing clinical trials to enable a successful registration and launch.
- Provide scientific input to the efficacy and safety endpoint objectives of a trial and assure efficient and innovative clinical study designs, collaborating closely with team members to assure feasibility of the clinical study.
- Provide clinical oversight of study execution in collaboration with all members of the clinical study team, in partnership with clinical operations.
- Support the development of program documents, including clinical protocols and the clinical sections of various regulatory documents such as clinical study reports, investigator brochures, annual reports and updates, and clinical sections of regulatory submissions to support product submissions and approvals.
- Collaborate with the clinical development team on the review, analysis, and interpretation of study results and assure appropriate data review and accurate data reporting.
- Identify study issues and program issues by reviewing and monitoring of emerging clinical data related to safety and efficacy.
- Develop sound, strategic solutions to issues and collaborate with the clinical team to ensure issue resolution.
- Prepare data for various presentations including peer-review publications.
- Maintain current knowledge of the external environment to ensure scientific innovations are considered and/or incorporated into clinical trial development strategy.
- Contribute to the development and standardization of templates, processes, infrastructure and procedures to support the clinical research needs of a growing organization.
- Oversee, manage and mentor a team of clinical scientists.
- Foster a collaborative and high-performing team environment.
- A dynamic individual who likes to lead and contribute as part of a passionate, growing team.
- RN, MS, PhD or PharmD, or equivalent with clinical research experience. Advanced degree and/or professional certification/credentials highly preferred.
- 5+ years of direct experience in clinical trial design, execution, and reporting, preferably in the pharmaceutical industry; oncology experience preferred.
- Experience managing direct reports and within a matrixed team environment.
- Thorough understanding of the drug development process from IND/CTA through BLA/NDA submission.
- Broad understanding of functional areas of drug development, including preclinical, regulatory, pharmacovigilance, drug supply, data sciences (data management, biostatistics, programming), and clinical operations (including site selection, study start-up, study conduct, and finalization).
- Demonstrated ability to communicate and write clearly, concisely, and effectively.
- Ability to understand, interpret and communicate clinical information including literature reviews, competitive intelligence, and changing treatment paradigms in order to apply knowledge to support a robust clinical development strategy.
- Understanding of trial design and statistics in order to apply knowledge to the design of clinical protocols.
- Ability to interpret, analyze, and present clinical data in order to inform decision-making and set clinical strategy.
- Well-organized: ability to prioritize tasks with a successful track record of managing multiple projects in a fast-paced and deadline-driven environment.
- Impeccable attention to detail.